# KISQALI

NDC: 0078-0874
Generic name: ribociclib
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20170313

FDA application: NDA209092

## Active ingredients

- RIBOCICLIB SUCCINATE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0874"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0874
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aaeaef94-f3f5-4367-8ea2-b181d7be2da8